Categories: DevelopmentDrugFastHealthTechInterest
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.07.2007 | - | $3.3M | - |
Mentions in press and media 2
| Date | Title | Description |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appetite for R&D risk | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. But from 2013 through 2015 generalist investors got over their fears and jumped into one of the hottest stock games on the planet. Fund... |
| 10.07.2007 | NephroGenex raises $3.3M for kidney disease | Cary, N.C.-based NephroGenex, a biotech developing personalized therapies for kidney disease, raised $3.3 million of an expected $26.8 million first funding round, VentureWire reports (subscription required), citing an SEC filing (no link a... |
Reviews 0
